Cardiovascular Events in Patients With Fabry Disease
Manesh R. Patel(Duke University), Ademola K. Abiose(Ohio Heart & Vascular Center), Michael L. West(Dalhousie University), Kathy Nicholls(Melbourne Health), Aleš Linhart(Charles University), Marta Cizmarik, Franco Cecchi(Azienda Ospedaliero-Universitaria Careggi), T.C.K. Tran(Erasmus MC), Dana Beitner‐Johnson, Ilkka Kantola(Turku University Hospital), Jörg Strotmann(Schmerzklinik Kiel), José Tallaj(University of Alabama at Birmingham Hospital)
Cited by 171
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2013|3.4k
Global vascular guidelines on the management of chronic limb-threatening ischemia
|Journal of Vascular Surgery|2019|1.9k
Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia
|European Journal of Vascular and Endovascular Surgery|2019|1.5k
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2021|1.1k